Showing 8,301 - 8,320 results of 15,870 for search '(( six ((we decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.89s Refine Results
  1. 8301

    Reliable Activation of Immature Neurons in the Adult Hippocampus by Lucas A. Mongiat (264874)

    Published 2009
    “…<div><p>Neurons born in the adult dentate gyrus develop, mature, and connect over a long interval that can last from six to eight weeks. …”
  2. 8302

    The effect of TRPV4 activation and KCa channel blockers on transepithelial electrical resistance (TEER) of mCCDcl1 cells grown to confluency on permeable supports (see Materials an... by Yue Li (102191)

    Published 2016
    “…</b> Representative example showing the effect of IK1 inhibition (TRAM-34) on the GSK101-activated TEER values. …”
  3. 8303
  4. 8304

    Supplementary Material for: Dispensaries and medical marijuana certifications and indications: Unveiling the geographic connections in Pennsylvania, USA by Hirsch A.G. (17961335)

    Published 2024
    “…We conducted a study to describe MMJ dispensary access in Pennsylvania and to determine whether dispensary proximity was associated with MMJ certifications and community demographics. …”
  5. 8305
  6. 8306

    DataSheet_1_Uric Acid Mediated the Association Between BMI and Postmenopausal Breast Cancer Incidence: A Bidirectional Mendelian Randomization Analysis and Prospective Cohort Study... by Yue Feng (158140)

    Published 2022
    “…In the DFTJ cohort, each standard deviation (SD) increment in BMI (3.5 kg/m<sup>2</sup>) and UA (75.4 μmol/l) was associated with a separate 24% and 22% increased risk of postmenopausal breast cancer [HR(95% CI) = 1.24(1.07, 1.44) and 1.22(1.05, 1.42), respectively]. …”
  7. 8307
  8. 8308
  9. 8309

    Supplementary Material for: Lymphocyte-to-Monocyte Ratio Predicts Survival for Intraductal Papillary Mucinous Neoplasm with Associated Invasive Carcinoma of the Pancreas: Results f... by Cui M. (12998331)

    Published 2024
    “…Conclusions: Preoperative LMR could serve as a feasible prognostic biomarker for IPMN-INV. A decreased LMR (cutoff value of 3.5) was an independent predictor of poor survival for IPMN-INV.…”
  10. 8310

    Pulpal blood flow changes and pain scores related to using Superelastic 0.018-inch Nickel Titanium as the first orthodontic alignment archwire: a prospective clinical trial by Elham S. Abu ALHAIJA (12681456)

    Published 2022
    “…Pain scores were recorded using a visual analogue scale (VAS). A repeated measures ANOVA and a post-hoc Bonferroni comparison tests were conducted to examine differences at the different time points before and during orthodontic alignment. …”
  11. 8311

    Unique Honey Bee (<i>Apis mellifera</i>) Hive Component-Based Communities as Detected by a Hybrid of Phospholipid Fatty-Acid and Fatty-Acid Methyl Ester Analyses by Kirk J. Grubbs (230447)

    Published 2015
    “…Averaging component lipid profiles by hive, we show that, in decreasing order, lipid markers representing fungi, Gram-negative bacteria, and Gram-positive bacteria have the highest relative abundances within honey bee colonies. …”
  12. 8312

    Data_Sheet_1_SIRT7-Induced PHF5A Decrotonylation Regulates Aging Progress Through Alternative Splicing-Mediated Downregulation of CDK2.DOCX by Ai Qing Yu (9774356)

    Published 2021
    “…Using modern mass spectrometry (MS) technology, we identified 5,149 Kcr sites across 1,541 proteins in senescent fibroblasts, and providing the largest crotonylome dataset to date in senescent cells. …”
  13. 8313

    Data_Sheet_1_Fungal Community, Not Substrate Quality, Drives Soil Microbial Function in Northeastern U.S. Temperate Forests.pdf by Amelia A. Fitch (9549359)

    Published 2020
    “…To assess this distinction, we sampled the organic horizon and 10 cm of the mineral horizon in northern temperate forest soils along a gradient of EcM dominance. …”
  14. 8314

    Data_Sheet_1_Fungal Community, Not Substrate Quality, Drives Soil Microbial Function in Northeastern U.S. Temperate Forests.pdf by Amelia A. Fitch (9549359)

    Published 2020
    “…To assess this distinction, we sampled the organic horizon and 10 cm of the mineral horizon in northern temperate forest soils along a gradient of EcM dominance. …”
  15. 8315

    “Submergence” of Western equine encephalitis virus: Evidence of positive selection argues against genetic drift and fitness reductions by Nicholas A. Bergren (8415759)

    Published 2020
    “…Previously, we showed using phylogenetics that during this period of decline, six amino acid residues appeared to be positively selected. …”
  16. 8316

    Table_1_Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy.doc by Rosaria Giordano (3548741)

    Published 2021
    “…Interleukin-8 serum concentrations decreased in three patients (Case 2, 3, and 4). An adaptive study design, appropriate and up-to-date efficacy measures, adequate sample size estimation, and, possibly, the use of a cellular and/or allogeneic cell sources may help in performing phase II trials in the field.…”
  17. 8317

    Image_1_Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy.pdf by Rosaria Giordano (3548741)

    Published 2021
    “…Interleukin-8 serum concentrations decreased in three patients (Case 2, 3, and 4). An adaptive study design, appropriate and up-to-date efficacy measures, adequate sample size estimation, and, possibly, the use of a cellular and/or allogeneic cell sources may help in performing phase II trials in the field.…”
  18. 8318

    Table_2_Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy.doc by Rosaria Giordano (3548741)

    Published 2021
    “…Interleukin-8 serum concentrations decreased in three patients (Case 2, 3, and 4). An adaptive study design, appropriate and up-to-date efficacy measures, adequate sample size estimation, and, possibly, the use of a cellular and/or allogeneic cell sources may help in performing phase II trials in the field.…”
  19. 8319
  20. 8320